WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Bioscience Neurolucida
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanchez, R. M.
Right arrow Articles by Jensen, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanchez, R. M.
Right arrow Articles by Jensen, F. E.

 Previous Article  |  Next Article 

The Journal of Neuroscience, March 15, 2000, 20(6):2409-2417

Novel Role for the NMDA Receptor Redox Modulatory Site in the Pathophysiology of Seizures

Russell M. Sanchez1, Carl Wang1, Ginger Gardner2, Lianna Orlando3, David L. Tauck4, Paul A. Rosenberg1, 3, Elias Aizenman5, and Frances E. Jensen1, 3

1 Department of Neurology, Children's Hospital and Harvard Medical School, Boston, Massachusetts, 2 Department of Obstetrics and Gynecology, Johns Hopkins Medical School, Baltimore, Maryland, 3 Program in Neuroscience, Harvard Medical School, Boston, Massachusetts, 4 Department of Biology, Santa Clara University, Santa Clara, California, and 5 Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Redox-active compounds modulate NMDA receptors (NMDARs) such that reduction of NMDAR redox sites increases, and oxidation decreases, NMDAR-mediated activity. Because NMDARs contribute to the pathophysiology of seizures, redox-active compounds also may modulate seizure activity. We report that the oxidant 5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB) and the redox cofactor pyrroloquinoline quinone (PQQ) suppressed low Mg2+-induced hippocampal epileptiform activity in vitro. Additionally, in slices exposed to 4-7 µM bicuculline, DTNB and PQQ reversed the potentiation of evoked epileptiform responses by the reductants dithiothreitol and Tris(2-carboxyethyl)phosphine (TCEP). NMDA-evoked whole-cell currents in CA1 neurons in slices were increased by TCEP and subsequently decreased by DTNB or PQQ at the same concentrations that modulated epileptiform activity. However, DTNB and PQQ had little effect on baseline NMDA-evoked currents in control medium, and PQQ did not alter NMDAR-dependent long-term potentiation. In contrast, in slices returned to control medium after low Mg2+-induced ictal activity, DTNB significantly inhibited NMDAR-mediated currents, indicating endogenous reduction of NMDAR redox sites under this epileptogenic condition. These data suggested that PQQ and DTNB suppressed spontaneous ictal activity by reversing pathological NMDAR redox potentiation without inhibiting physiological NMDAR function. In vivo, PQQ decreased the duration of chemoconvulsant-induced seizures in rat pups with no effect on baseline behavior. Our results reveal endogenous potentiation of NMDAR function via mass reduction of redox sites as a novel mechanism that may enhance epileptogenesis and facilitate the transition to status epilepticus. The results further suggest that redox-active compounds may have therapeutic use by reversing NMDAR-mediated pathophysiology without blocking physiological NMDAR function.

Key words: NMDA receptor; redox; epilepsy; hippocampus; patch clamp; PQQ


Copyright © 2000 Society for Neuroscience  0270-6474/00/2062409-09$05.00/0


This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
S. Hepp, F. J. Gerich, and M. Muller
Sulfhydryl Oxidation Reduces Hippocampal Susceptibility to Hypoxia-Induced Spreading Depression by Activating BK Channels
J Neurophysiol, August 1, 2005; 94(2): 1091 - 1103.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. V. Avshalumov and M. E. Rice
NMDA Receptor Activation Mediates Hydrogen Peroxide-Induced Pathophysiology in Rat Hippocampal Slices
J Neurophysiol, June 1, 2002; 87(6): 2896 - 2903.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. G. Mueller, A. H. Trabesinger, P. Boesiger, and H. G. Wieser
Brain glutathione levels in patients with epilepsy measured by in vivo 1H-MRS
Neurology, October 23, 2001; 57(8): 1422 - 1427.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. M. Sanchez, S. Koh, C. Rio, C. Wang, E. D. Lamperti, D. Sharma, G. Corfas, and F. E. Jensen
Decreased Glutamate Receptor 2 Expression and Enhanced Epileptogenesis in Immature Rat Hippocampus after Perinatal Hypoxia-Induced Seizures
J. Neurosci., October 15, 2001; 21(20): 8154 - 8163.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-